Research Triangle-based StrideBio, a startup focusing on gene editing technology, inked a deal with Massachusetts-based Sarepta Therapeutics for a deal worth nearly $90 million plus future…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.